Literature DB >> 2038426

Combined treatment modality for medulloblastoma in childhood: effects on neuropsychological functioning.

D Riva1, N Milani, C Pantaleoni, E Ballerini, C Giorgi.   

Abstract

8 long-surviving children, treated for medulloblastoma with combination radiotherapy and chemotherapy after surgery were examined in order to assess general intelligence, immediate attention and prolonged attention. Their siblings or first cousins were selected as controls. The children with medulloblastoma performed significantly worse than their peers, both in intelligence tests and attention tests. A trend towards a positive correlation between age at the start of treatment and IQs was confirmed in our study, while there was no evidence of a correlation between IQs and time elapsed from therapy. The role of chemotherapy, radiotherapy and their combination effect in producing neuropsychological sequelae is discussed.

Entities:  

Mesh:

Year:  1991        PMID: 2038426     DOI: 10.1055/s-2008-1071413

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

1.  Cerebellar mutism: definitions, classification and grading of symptoms.

Authors:  Thora Gudrunardottir; Astrid Sehested; Marianne Juhler; Jacques Grill; Kjeld Schmiegelow
Journal:  Childs Nerv Syst       Date:  2011-07-06       Impact factor: 1.475

2.  Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma.

Authors:  Ann M Maddrey; Jon A Bergeron; Elizabeth R Lombardo; Noelle K McDonald; Arlynn F Mulne; Paul D Barenberg; Daniel C Bowers
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

Review 3.  Initial management of childhood brain tumors: neurosurgical considerations.

Authors:  Farideh Nejat; Mostafa El Khashab; James T Rutka
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

4.  Cognition before and after chemotherapy alone in children with chiasmatic-hypothalamic tumors.

Authors:  Daria Riva; Maura Massimino; Cesare Giorgi; Francesca Nichelli; Alessandra Erbetta; Arianna Usilla; Chiara Vago; Sara Bulgheroni
Journal:  J Neurooncol       Date:  2008-11-14       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.